The University of Southampton
University of Southampton Institutional Repository

Steatotic liver disease subtypes exhibit distinct risk patterns of tachyarrhythmias and bradyarrhythmias

Steatotic liver disease subtypes exhibit distinct risk patterns of tachyarrhythmias and bradyarrhythmias
Steatotic liver disease subtypes exhibit distinct risk patterns of tachyarrhythmias and bradyarrhythmias
Background and aims: steatotic liver disease (SLD) is independently associated with cardiovascular disease; however, data on cardiac arrhythmias across individual SLD subtypes remain scarce. This study aimed to investigate associations between distinct SLD subtypes and arrhythmia risk.

Methods: using prospective UK Biobank data, participants were classified into four groups: no-SLD, metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol–associated steatotic liver disease (MetALD), and alcohol–associated liver disease (ALD). The primary outcome was incident overall arrhythmias, and secondary outcomes were specific arrhythmia subtypes. Multivariable Cox proportional hazards models assessed associations, and exploratory analyses evaluated subtype‑specific risk patterns.

Results: among 428,609 participants followed for a median of 14.23 years (IQR: 12.64–15.30), the cumulative incidence of arrhythmias increased progressively from no-SLD to MASLD, MetALD, and ALD (8.22%, 13.60%, 14.15%, and 16.43%, respectively). All SLD subtypes were independently associated with a higher risk of overall arrhythmias (MASLD: aHR = 1.39, 95% CI 1.36–1.42; MetALD: aHR = 1.43, 95% CI 1.38–1.48; ALD: aHR = 1.65, 95% CI 1.57–1.74; all P < 0.001). Atrial fibrillation and flutter (AF/AFL) accounted for 85.39% of tachyarrhythmias, and risk increased stepwise across the MASLD–MetALD–ALD spectrum. In contrast, bradyarrhythmias showed a distinct risk hierarchy, with MetALD conferring the highest risk (aHR = 1.44, 95% CI 1.32–1.56; P < 0.001), followed by MASLD (aHR = 1.39, 95% CI 1.32–1.47; P < 0.001) and ALD (aHR = 1.38, 95% CI 1.21–1.58; P < 0.001). Exploratory analyses suggested that alcohol‑related subtypes were more strongly associated with tachyarrhythmias than with bradyarrhythmias.

Conclusion: SLD subtypes were independently associated with a higher risk of incident arrhythmias, and the risk of AF/AFL increased stepwise across the MASLD–MetALD–ALD spectrum. Bradyarrhythmia risk was predominantly observed in metabolically related SLD subtypes. These findings suggest that SLD subtype classification is a relevant consideration for future risk stratification research, although its clinical applicability warrants further investigation.

1475-2840
Lin, Ya
c10fe8b1-89f7-4e77-a973-9c9e86725c11
Chen, Qin-Fen
c923bf6e-f46a-4a3b-94a2-b6a54b23c0e5
Xia, Tianyi
be721a58-5e19-42b6-a2a0-6c54f106aa66
Byrne, Chris
1370b997-cead-4229-83a7-53301ed2a43c
et al.
CHAIN Consortium
Lin, Ya
c10fe8b1-89f7-4e77-a973-9c9e86725c11
Chen, Qin-Fen
c923bf6e-f46a-4a3b-94a2-b6a54b23c0e5
Xia, Tianyi
be721a58-5e19-42b6-a2a0-6c54f106aa66
Byrne, Chris
1370b997-cead-4229-83a7-53301ed2a43c

Lin, Ya, Chen, Qin-Fen and Xia, Tianyi , et al. and CHAIN Consortium (2026) Steatotic liver disease subtypes exhibit distinct risk patterns of tachyarrhythmias and bradyarrhythmias. Cardiovascular Diabetology. (doi:10.1186/s12933-026-03305-x).

Record type: Article

Abstract

Background and aims: steatotic liver disease (SLD) is independently associated with cardiovascular disease; however, data on cardiac arrhythmias across individual SLD subtypes remain scarce. This study aimed to investigate associations between distinct SLD subtypes and arrhythmia risk.

Methods: using prospective UK Biobank data, participants were classified into four groups: no-SLD, metabolic dysfunction–associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol–associated steatotic liver disease (MetALD), and alcohol–associated liver disease (ALD). The primary outcome was incident overall arrhythmias, and secondary outcomes were specific arrhythmia subtypes. Multivariable Cox proportional hazards models assessed associations, and exploratory analyses evaluated subtype‑specific risk patterns.

Results: among 428,609 participants followed for a median of 14.23 years (IQR: 12.64–15.30), the cumulative incidence of arrhythmias increased progressively from no-SLD to MASLD, MetALD, and ALD (8.22%, 13.60%, 14.15%, and 16.43%, respectively). All SLD subtypes were independently associated with a higher risk of overall arrhythmias (MASLD: aHR = 1.39, 95% CI 1.36–1.42; MetALD: aHR = 1.43, 95% CI 1.38–1.48; ALD: aHR = 1.65, 95% CI 1.57–1.74; all P < 0.001). Atrial fibrillation and flutter (AF/AFL) accounted for 85.39% of tachyarrhythmias, and risk increased stepwise across the MASLD–MetALD–ALD spectrum. In contrast, bradyarrhythmias showed a distinct risk hierarchy, with MetALD conferring the highest risk (aHR = 1.44, 95% CI 1.32–1.56; P < 0.001), followed by MASLD (aHR = 1.39, 95% CI 1.32–1.47; P < 0.001) and ALD (aHR = 1.38, 95% CI 1.21–1.58; P < 0.001). Exploratory analyses suggested that alcohol‑related subtypes were more strongly associated with tachyarrhythmias than with bradyarrhythmias.

Conclusion: SLD subtypes were independently associated with a higher risk of incident arrhythmias, and the risk of AF/AFL increased stepwise across the MASLD–MetALD–ALD spectrum. Bradyarrhythmia risk was predominantly observed in metabolically related SLD subtypes. These findings suggest that SLD subtype classification is a relevant consideration for future risk stratification research, although its clinical applicability warrants further investigation.

Text
Reviewed_manuscript_with_highlighted20260715 - Accepted Manuscript
Download (223kB)
Text
Supplementary Tables20260703 - Accepted Manuscript
Download (84kB)
Text
Tables20260703 - Accepted Manuscript
Download (49kB)
Text
Figures20260709 - Accepted Manuscript
Download (555kB)
Text
Supplementary Figures20260707 - Accepted Manuscript
Download (2MB)

Show all 5 downloads.

More information

Accepted/In Press date: 16 July 2026
e-pub ahead of print date: 22 August 2026

Identifiers

Local EPrints ID: 515077
URI: https://eprints.soton.ac.uk/id/eprint/515077
ISSN: 1475-2840
PURE UUID: 93987f86-d777-453a-82a1-1cee8a85f8da
ORCID for Chris Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 05 Oct 2026 16:53
Last modified: 10 Oct 2026 01:39

Export record

Altmetrics

Contributors

Author: Ya Lin
Author: Qin-Fen Chen
Author: Tianyi Xia
Author: Chris Byrne ORCID iD
Corporate Author: et al.
Corporate Author: CHAIN Consortium

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×